Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Trivano
Alles over “Fabricage van farmaceutische preparaten”
Aandelen in “Fabricage van farmaceutische preparaten”
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Aandeel
Datum
Koers
Evolutie
Even geduld...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Nieuws over “Fabricage van farmaceutische preparaten”
Toon enkel gratis nieuws
22:54 ·
Sanofi: Information concerning the total number of voting rights and shares - April 2024
· Persbericht
22:54 ·
Sanofi: Information concerning the total number of voting rights and shares - April 2024
· Persbericht
22:28 ·
Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International Conference Plenary Session
· Persbericht
20:15 ·
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM
· Persbericht
14:30 ·
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine
· Persbericht
13:30 ·
Soligenix Encourages Stockholders to Vote Prior to Annual Meeting
· Persbericht
13:00 ·
PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation
· Persbericht
17/05 ·
BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification
· Persbericht
17/05 ·
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®
· Persbericht
17/05 ·
Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
· Persbericht
17/05 ·
AKRO Investors: Reminder - Important Deadline in Securities Fraud Class Action Lawsuit Akero Therapeutics, Inc.
· Persbericht
16/05 ·
Galapagos creates new subscription right plans
· Persbericht
16/05 ·
Galapagos creëert nieuwe inschrijvingsrechtenplannen
· Persbericht
16/05 ·
Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress
· Persbericht
16/05 ·
Regulus Therapeutics Announces Promotion of Rekha Garg, M.D., M.S., to Chief Medical Officer
· Persbericht
16/05 ·
Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
· Persbericht
16/05 ·
Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice
· Persbericht
16/05 ·
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte
· Persbericht
16/05 ·
Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome
· Persbericht
16/05 ·
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
· Persbericht
15/05 ·
Galapagos gaat kankertherapie produceren in Amerikaanse bloedcentra
· Tijd.be (€)
Het beursgenoteerde Mechelse biotechbedrijf Galapagos gaat samenwerken met Blood Centers of America, het grootste Amerikaanse bloedvoorzieningsnetwerk, om er lokaal zijn gepersonaliseerde kankerbehand...
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe